
Seung H. Lee
Examiner (ID: 8709, Phone: (571)272-2401 , Office: P/2887 )
| Most Active Art Unit | 2876 |
| Art Unit(s) | 2887, 2876 |
| Total Applications | 2203 |
| Issued Applications | 1831 |
| Pending Applications | 152 |
| Abandoned Applications | 248 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 5023543
[patent_doc_number] => 20070149509
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-06-28
[patent_title] => 'Use of vitamin e'
[patent_app_type] => utility
[patent_app_number] => 10/582906
[patent_app_country] => US
[patent_app_date] => 2004-12-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 1073
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0149/20070149509.pdf
[firstpage_image] =>[orig_patent_app_number] => 10582906
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/582906 | Use of vitamin e | Dec 8, 2004 | Abandoned |
Array
(
[id] => 6931876
[patent_doc_number] => 20050282911
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-12-22
[patent_title] => 'Memantine for the prevention or reduction of suicidality and for treatment of major depression associated with suicidality'
[patent_app_type] => utility
[patent_app_number] => 11/006487
[patent_app_country] => US
[patent_app_date] => 2004-12-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 6236
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0282/20050282911.pdf
[firstpage_image] =>[orig_patent_app_number] => 11006487
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/006487 | Memantine for the prevention or reduction of suicidality and for treatment of major depression associated with suicidality | Dec 5, 2004 | Abandoned |
Array
(
[id] => 281858
[patent_doc_number] => 07553858
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2009-06-30
[patent_title] => 'Combination of flupirtine and tramadol'
[patent_app_type] => utility
[patent_app_number] => 11/002762
[patent_app_country] => US
[patent_app_date] => 2004-12-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4009
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 44
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/553/07553858.pdf
[firstpage_image] =>[orig_patent_app_number] => 11002762
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/002762 | Combination of flupirtine and tramadol | Dec 2, 2004 | Issued |
Array
(
[id] => 5716151
[patent_doc_number] => 20060079514
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-04-13
[patent_title] => 'Methods and compositions including methscopolamine bromide'
[patent_app_type] => utility
[patent_app_number] => 11/001748
[patent_app_country] => US
[patent_app_date] => 2004-12-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2610
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0079/20060079514.pdf
[firstpage_image] =>[orig_patent_app_number] => 11001748
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/001748 | Methods and compositions including methscopolamine bromide | Dec 1, 2004 | Abandoned |
Array
(
[id] => 7050401
[patent_doc_number] => 20050186288
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-08-25
[patent_title] => 'Compositions and methods for the prophylaxis and treatment of aphthous ulcers and herpes simplex lesions'
[patent_app_type] => utility
[patent_app_number] => 10/999988
[patent_app_country] => US
[patent_app_date] => 2004-12-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9139
[patent_no_of_claims] => 31
[patent_no_of_ind_claims] => 10
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0186/20050186288.pdf
[firstpage_image] =>[orig_patent_app_number] => 10999988
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/999988 | Compositions and methods for the prophylaxis and treatment of aphthous ulcers and herpes simplex lesions | Nov 30, 2004 | Abandoned |
Array
(
[id] => 6918738
[patent_doc_number] => 20050096299
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-05-05
[patent_title] => 'Method for inhibiting bone resorption'
[patent_app_type] => utility
[patent_app_number] => 11/000199
[patent_app_country] => US
[patent_app_date] => 2004-11-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 10015
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0096/20050096299.pdf
[firstpage_image] =>[orig_patent_app_number] => 11000199
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/000199 | Method for inhibiting bone resorption | Nov 29, 2004 | Abandoned |
Array
(
[id] => 5142508
[patent_doc_number] => 20070004724
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-01-04
[patent_title] => '(+)-(2S,3s)-2-(3-chlorophenyl)-3,5,5-trimethyl-2-morpholinor for treating anxiety'
[patent_app_type] => utility
[patent_app_number] => 10/595916
[patent_app_country] => US
[patent_app_date] => 2004-11-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 5064
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0004/20070004724.pdf
[firstpage_image] =>[orig_patent_app_number] => 10595916
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/595916 | (+)-(2S,3s)-2-(3-chlorophenyl)-3,5,5-trimethyl-2-morpholinor for treating anxiety | Nov 24, 2004 | Abandoned |
Array
(
[id] => 860529
[patent_doc_number] => 07371756
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2008-05-13
[patent_title] => 'Use of 1-[4-(5-cyanoindol-3-yl)butyl]-4-(2-carbamoyl-benzofuran-5-yl)-piperazine and its physiologically acceptable salts'
[patent_app_type] => utility
[patent_app_number] => 10/994226
[patent_app_country] => US
[patent_app_date] => 2004-11-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9739
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 46
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/371/07371756.pdf
[firstpage_image] =>[orig_patent_app_number] => 10994226
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/994226 | Use of 1-[4-(5-cyanoindol-3-yl)butyl]-4-(2-carbamoyl-benzofuran-5-yl)-piperazine and its physiologically acceptable salts | Nov 22, 2004 | Issued |
Array
(
[id] => 5189141
[patent_doc_number] => 20070167450
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-07-19
[patent_title] => 'Agent for treating chronic pelvic pain syndrome'
[patent_app_type] => utility
[patent_app_number] => 10/580417
[patent_app_country] => US
[patent_app_date] => 2004-11-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 4536
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0167/20070167450.pdf
[firstpage_image] =>[orig_patent_app_number] => 10580417
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/580417 | Agent for treating chronic pelvic pain syndrome | Nov 17, 2004 | Abandoned |
Array
(
[id] => 5022227
[patent_doc_number] => 20070148193
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-06-28
[patent_title] => 'Lutein concentrate'
[patent_app_type] => utility
[patent_app_number] => 10/576272
[patent_app_country] => US
[patent_app_date] => 2004-11-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 1113
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0148/20070148193.pdf
[firstpage_image] =>[orig_patent_app_number] => 10576272
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/576272 | Lutein concentrate | Nov 17, 2004 | Abandoned |
Array
(
[id] => 6906260
[patent_doc_number] => 20050101655
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-05-12
[patent_title] => 'Migraine treatments including isovaleramide compounds and serotonin agonists'
[patent_app_type] => utility
[patent_app_number] => 10/987760
[patent_app_country] => US
[patent_app_date] => 2004-11-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 5062
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0101/20050101655.pdf
[firstpage_image] =>[orig_patent_app_number] => 10987760
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/987760 | Migraine treatments including isovaleramide compounds and serotonin agonists | Nov 11, 2004 | Abandoned |
Array
(
[id] => 6911930
[patent_doc_number] => 20050175688
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-08-11
[patent_title] => 'Method of treating pain in a subject by the administration of aminobenzoate potassium'
[patent_app_type] => utility
[patent_app_number] => 10/970542
[patent_app_country] => US
[patent_app_date] => 2004-10-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4094
[patent_no_of_claims] => 32
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0175/20050175688.pdf
[firstpage_image] =>[orig_patent_app_number] => 10970542
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/970542 | Method of treating pain in a subject by the administration of aminobenzoate potassium | Oct 21, 2004 | Abandoned |
Array
(
[id] => 7143027
[patent_doc_number] => 20050118286
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-06-02
[patent_title] => 'Compositions and methods for treatment of nervous system disorders'
[patent_app_type] => utility
[patent_app_number] => 10/972188
[patent_app_country] => US
[patent_app_date] => 2004-10-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 43057
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0118/20050118286.pdf
[firstpage_image] =>[orig_patent_app_number] => 10972188
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/972188 | Compositions and methods for treatment of nervous system disorders | Oct 21, 2004 | Abandoned |
Array
(
[id] => 7005893
[patent_doc_number] => 20050171206
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-08-04
[patent_title] => 'Therapeutical use'
[patent_app_type] => utility
[patent_app_number] => 10/971527
[patent_app_country] => US
[patent_app_date] => 2004-10-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 7007
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0171/20050171206.pdf
[firstpage_image] =>[orig_patent_app_number] => 10971527
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/971527 | Therapeutical use | Oct 20, 2004 | Abandoned |
Array
(
[id] => 5085042
[patent_doc_number] => 20070275093
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-11-29
[patent_title] => 'Methods for Treating Non-Microbial Inflammatory Skin Conditioners'
[patent_app_type] => utility
[patent_app_number] => 10/576396
[patent_app_country] => US
[patent_app_date] => 2004-10-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 8848
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0275/20070275093.pdf
[firstpage_image] =>[orig_patent_app_number] => 10576396
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/576396 | Methods for Treating Non-Microbial Inflammatory Skin Conditioners | Oct 18, 2004 | Abandoned |
Array
(
[id] => 6939882
[patent_doc_number] => 20050113445
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-05-26
[patent_title] => 'Methods of treating mental diseases, inflammation and pain'
[patent_app_type] => utility
[patent_app_number] => 10/967954
[patent_app_country] => US
[patent_app_date] => 2004-10-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 1793
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0113/20050113445.pdf
[firstpage_image] =>[orig_patent_app_number] => 10967954
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/967954 | Methods of treating mental diseases, inflammation and pain | Oct 18, 2004 | Abandoned |
Array
(
[id] => 5716150
[patent_doc_number] => 20060079513
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-04-13
[patent_title] => 'Methods and compositions including methscopolamine nitrate'
[patent_app_type] => utility
[patent_app_number] => 10/964252
[patent_app_country] => US
[patent_app_date] => 2004-10-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2934
[patent_no_of_claims] => 43
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0079/20060079513.pdf
[firstpage_image] =>[orig_patent_app_number] => 10964252
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/964252 | Methods and compositions including methscopolamine nitrate | Oct 12, 2004 | Abandoned |
Array
(
[id] => 5715264
[patent_doc_number] => 20060078627
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-04-13
[patent_title] => 'Composition for treatment of obesity or generally aiding weight loss in pill, powder or liquid form, by appetite reduction and metabolism increase, comprising: L- phenylalanine, caffeine, and one or more of the group of all forms of 5-hydroxytryptophan and L-tryptophan, all from either natural or synthetic sources'
[patent_app_type] => utility
[patent_app_number] => 10/959973
[patent_app_country] => US
[patent_app_date] => 2004-10-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2008
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0078/20060078627.pdf
[firstpage_image] =>[orig_patent_app_number] => 10959973
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/959973 | Composition for treatment of obesity or generally aiding weight loss in pill, powder or liquid form, by appetite reduction and metabolism increase, comprising: L- phenylalanine, caffeine, and one or more of the group of all forms of 5-hydroxytryptophan and L-tryptophan, all from either natural or synthetic sources | Oct 7, 2004 | Abandoned |
Array
(
[id] => 6939886
[patent_doc_number] => 20050113449
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-05-26
[patent_title] => 'Enhanced efficacy of omega-3 fatty acid therapy in the treatment of psychiatric disorders and other indications'
[patent_app_type] => utility
[patent_app_number] => 10/961288
[patent_app_country] => US
[patent_app_date] => 2004-10-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3425
[patent_no_of_claims] => 33
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0113/20050113449.pdf
[firstpage_image] =>[orig_patent_app_number] => 10961288
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/961288 | Enhanced efficacy of omega-3 fatty acid therapy in the treatment of psychiatric disorders and other indications | Oct 7, 2004 | Abandoned |
Array
(
[id] => 5720398
[patent_doc_number] => 20060073172
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-04-06
[patent_title] => 'Stabilized ophthalmic solution for the treatment of glaucoma and lowering intraocular pressure'
[patent_app_type] => utility
[patent_app_number] => 10/956865
[patent_app_country] => US
[patent_app_date] => 2004-10-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 6185
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0073/20060073172.pdf
[firstpage_image] =>[orig_patent_app_number] => 10956865
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/956865 | Stabilized ophthalmic solution for the treatment of glaucoma and lowering intraocular pressure | Sep 30, 2004 | Abandoned |